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Background: Tumours of the central nervous system are the second most common group of childhood cancers in
0–14 year olds (24% of total cancers) and represent a major diagnostic group in 15–24 year olds. The pilot case–control
study aimed to establish methodologies for a future comprehensive aetiological investigation among children and
young adults.
Methods: Eligible cases were newly diagnosed with an intracranial tumour of neuroepithelial tissue aged 0–24 years.
The pilot recruited patients through Leeds and Manchester Principal Treatment Centres. Controls were drawn from
general practice lists. Controls were frequency matched by age and gender.
Results: We interviewed 49 cases and 78 controls comprising 85% of the target sample size. Response rates were 52%
for cases and 32% for controls. Completion of the questionnaire was successful, with a very small proportion of missing
data being reported (5-10%). The age distribution of cases and controls was similar with around three-quarters of
interviewed subjects aged 0–14. Half of cases and almost two-thirds of controls reported using a mobile phone with
the majority starting between 10–14 years of age. Prevalence of breastfeeding was lower in cases than controls (Odds
Ratio 0.4; 95% CI 0.2-1.2), whilst cases were more likely to be delivered by caesarean section (OR 1.6; 95% CI 0.6-4.4).
Cases were significantly more likely to have a birthweight > 3.5 kg compared to controls. Cases were also more likely to
come from a family with 3 or more siblings than controls (OR 3.0; 95% CI 0.7-13.6). The majority of participants (>80%)
were in favour of taking either blood or saliva to aid molecular epidemiological research.
Conclusions: Successful methods were established for identifying and recruiting a high proportion of case subjects,
exploiting strong links with the clinical teams at the treatment centres. Control procedures proved more difficult to
implement. However, working closely with national clinical and professional research networks will enable improved
control identification and recruitment, with good prospects for collecting biological samples in the future.
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Tumours of the central nervous system (CNS) are the
second most common group of childhood cancers com-
prising a quarter of all malignancies in patients aged
0–14 years with approximately 350 children diagnosed
each year in the UK [1]. CNS tumours also represent a
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reproduction in any medium, provided the oraged 15–24 years with around 150 new cases per year
diagnosed in the UK representing 10% of all cancers in
this age range [2]. Survival rates for CNS tumours in
young people are generally poor when compared to
other cancers occurring among 0–24 year olds: around
50% of these patients die from their disease and those
who survive are at particular risk of severely debilitating
late effects [3].
CNS tumours presenting in the young differ notably
from those in older adults in terms of the cellular ori-
gins, pathological subtypes and anatomic site. The mostral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(50%) and embryonal tumours including medulloblastoma
(25%) [4]. Apart from an increasing number of cancer
predisposition syndromes associated with early onset
CNS tumours, the causes of CNS tumours in children
and young adults remain largely unknown.
The only established environmental risk factor for CNS
tumours is ionising radiation [5-8]. Exposure to N-nitroso
compounds through consumption of cured meat during
pregnancy has been consistently reported as an aetiological
factor [6,7]. Childhood CNS tumours have also been
linked to residential pesticide exposure, traffic pollution,
and parental occupations [8-11]. There is accumulating
evidence of links between infections and CNS tumours
particularly in the young. Supportive evidence for the
involvement of infections comes from analyses of space-
time clustering of incident cases, geographical and
demographic variations in incidence and population
mixing [12-16].
Pre-school nurseries have a high prevalence and diversity
of infectious disease (e.g. [17]) and attendance can be
considered a proxy for early exposure to infections.
Exposure to infection in early life has been investigated
in the context of a potential infectious aetiology for
childhood type CNS tumours although findings have
been inconsistent, varying according to tumour type and
exposure of interest [18,19]. Atopic diseases, such as
asthma, eczema and allergies, can be markers of immune
dysfunction. There is evidence to suggest that atopic
conditions may confer a reduced risk of CNS tumours
in children [20,21]. Furthermore, specific HLA alleles
and haplotypes are associated with relatively higher or
lower risks of childhood ALL and possibly also CNS
tumours [22,23]. Higher birthweight, especially those
born weighing over 4000 g, has also been implicated as
a possible causal risk factor for childhood brain tumours
[24], whilst a protective association has been described for
maternal farm residence during pregnancy and postnatal
contact with birds [25].
As a forerunner to a population-based case control study
of neuroepithelial CNS tumours in children, teenagers
and young adults we aimed to undertake a pilot study
involving a multidisciplinary team comprising paediatric
and adolescent oncologists, research nurses, and epi-
demiologists. The aims were to 1) establish procedures for
optimal case and control ascertainment, 2) pilot a ques-
tionnaire and study materials, 3) optimise the collection
and storage of biological samples 4) develop a protocol
and grant application for the full study.
Methods
Case–control selection
Eligible cases were those children and young people
who were aged 0–24 years at diagnosis presenting witha primary intracranial tumour of neuroepithelial tissue
as defined by WHO classification [4]. Tumours were
classified into the following subtypes: ependymoma,
astrocytoma, embryonal and other specified tumours.
Cases were identified through clinical teams based in
the two UK Principal Treatment Centres of Leeds and
Manchester, comprising dedicated paediatric and Teenage
and Young Adult oncology units. Approaches to patients/
parents were made at a time recommended by the clinical
teams. Written, informed consent to take part in the pilot
study was obtained. Response rates were assessed by age
group, gender, CNS subtype and centre.
Controls from the Leeds centre were randomly selected
from general practice (GP) lists to identify a population-
based sample and provide access to medical records. As
part of the feasibility process, controls were frequency
matched according to the age (0–24 years) and sex distri-
bution of the case sample. GP practices were selected
whose population demographic (age, sex, social class
and population density) reflected those of the larger
geographical area. Once approval was obtained, a study
administrator based themselves in the practice and ran-
domly selected a list of eligible participants. Study invitation
letters were distributed on behalf of the person’s GP.
Where a control refused to take part, replacement controls
were used and the socio-demographic breakdown of
response rates monitored to assess the representation
of the participants. From the Manchester centre, three
friend controls who fulfilled the required age and sex
were selected and interviewed. Numerous GP practices
were approached but despite extensive efforts and involve-
ment with the Primary Care Research Network (PCRN), a
group which supports clinical research studies involving
primary care services in England, we were unable to
recruit any practices (see Results).
The pilot study set out to recruit and interview 25 cases
and 50 controls per centre (50 cases and 100 controls
in total).
Interview materials and processes
Exposure prevalence was assessed through information
collected from face-to-face interviews. The interview
proforma was designed to be compatible with a large
parallel international case–control study covering the
Nordic countries [26], a copy of which is provided in the
Additional file 1. For each centre, an experienced
research nurse co-ordinated and conducted interviews
with participants and their families. Information was
collected on the health of the young person, parental
health, the index person’s early social habits as a child
and the family histories of cancer for cases. Information
was captured by a trained interviewer who administered
either a Computer Assisted Personal Interview (CAPI)
questionnaire adapted from a parallel Nordic study [26],
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ferred onto a Microsoft Access database. Parental inter-
views were undertaken for those aged under 12 years; for
older subjects, both parents and cases were interviewed
(Additional file 1).
Ethical approval for the study was granted by the North
West Research Ethics Committee in July 2007 (reference
number 07/MRE08/46) and informed consent obtained
for every participant. The study conformed to the prin-
ciples embodied in the Declaration of Helsinki. The recruit-
ment periods were September 2007 to March 2009 in
Leeds and June 2008 to June 2010 in Manchester.
Statistical analysis
Conditional logistic regression stratified by age (5-year
age groups) and sex was undertaken to derive odds ratios
(OR) and 95% CI. Adjustment for deprivation was carried
out using the Townsend score of the child’s address at
diagnosis by the use of Townsend score quintiles based on
the UK population distribution. In view of the limited
sample size and power and range of possible aetiological
factors involved in the development of CNS tumours in
children and young people, we undertook a careful regres-
sion analysis including a small number of risk factors
which were deemed important based on the epidemio-
logical literature (breastfeeding, caesarean section, birth-
weight, number of siblings, mobile phone usage, contact
with animals). A full list of risk factors collected from the
interviews is provided in the Additional file 1. All analyses
were carried out using Stata version 12.1.Eligible
Case Control
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Figure 1 Recruitment flowchart (all centres combined).Results
Recruitment and participant characteristics
Aggregating the data from across both centres yielded
49 cases and 78 controls who were interviewed. Overall,
although both centres experienced some problems in
terms of recruitment, across both centres we recruited
85% of the target sample size. The flowchart in Figure 1
describes the recruitment pathways and number of sub-
jects identified at each stage for both centres combined.
Table 1 summarises the age, sex and CNS subtype dis-
tribution by case and control status. 81% of cases were
aged 0–14 years at interview compared to two-thirds of
controls. There was a notable excess of controls diagnosed
aged 15–19 (22%) compared to cases (10%). Slightly more
cases were male (59%) with a slightly higher percentage of
controls being female (53%).
Response rates were 52% and 32% for cases and controls
respectively out of those who were eligible for the study
(Figure 1). We found recruitment to be a significant chal-
lenge notably for cases in Leeds and controls in Manchester.
These were largely attributable to changes in NHS govern-
ance and the GP contract during the recruitment phase.
Main reasons for not taking part were reported as
refusal (4 cases and 27 controls from Leeds; 9 cases from
Manchester) and untraceable subjects (5 cases and 139
controls from Leeds; 15 cases from Manchester). Comple-
tion of the questionnaire however was a success, with a
very small proportion of missing data being reported
(typically 5-10% for each variable). Where missing data
were present, this largely related to the same individuals.Interviewed
Case Control
49 (52.1%)      78 (31.6%)
Parent/Patient
Case Control
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Consultant
Case   Control















Table 1 Demographic characteristics of the study
participants according to case (n = 49) and control
(n = 78) status
Cases Controls
n % n %
Age
0-4 16 32.7 19 24.4
5-9 13 26.5 16 20.5
10-14 11 22.5 17 21.8
15-19 5 10.2 17 21.8
20-24 4 8.2 9 11.5
Sex
Male 29 59.3 34 46.8
Female 20 40.7 44 53.2
Study centre
Leeds 18 36.7 76 97.4
Manchester 31 63.3 2 2.6




Other specified 3 6.1
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cases who did not take part and it was found that there was
no significant difference in Townsend score between the
two groups. In the Leeds area deprivation was available
for interviewed and non-interviewed controls and when
comparing deprivation quintile there was found to be a
significant trend of reducing participation with increasing
quintiles of deprivation (OR: 0.6, 95% CI: 0.5-0.8, p < 0.001).
Half of cases and almost two-thirds of controls indicated
that they had used a mobile phone (Table 2). The majority
of respondents who used a mobile device began doing so
when they were 10–14 years of age. Excluding missing
data, the prevalence of breastfeeding was lower in cases
(73%) compared to controls (83%), whilst cases (25%) were
more likely to be delivered by caesarean section than
controls (15%) (Table 2). 61% of cases had a birthweight
in excess of 3.5 kg compared to only 36% of controls.
Cases were also more likely to come from a family with 3
or more siblings (31%) than controls (12%). A lower
proportion of cases (29%) reported having regular contact
with animals outside than controls (40%) (Table 2).
Logistic regression modelling for selected birth related
and environmental factors (Table 2) showed some evi-
dence of a reduced risk for ever having being breastfed
(OR: 0.4, 95% CI: 0.2-1.2). There was a statistically signifi-
cant finding of increased risk with increased birth weight
compared to normal weight (3500-3999 g OR: 2.9, 95%
CI: 1.0-8.2, ≥4000 g, OR: 3.7, 95% CI: 1.1-12.4). Otherfactors explored did not appear to have an association with
brain tumour risk.
Of the 12 cases and 25 controls who responded about
their willingness to provide a blood or saliva sample to
carry out future biological research, all cases and controls
said they would agree to provide saliva whilst 89% of
cases and 81% of controls would agree to provide a
blood sample.
Discussion
Through this pilot study, we have demonstrated that by
working closely as a multidisciplinary team, recruitment
of participants diagnosed with brain tumours is feasible
as part of a ‘case-control’ design to address aetiological
questions, despite the huge challenges facing these young
people shortly after diagnosis.
In terms of addressing the aims of the study, we devel-
oped successful methods for identifying and recruiting a
high proportion of case subjects by exploiting our strong
links with local clinicians and research nurses. Control
procedures proved more difficult; nonetheless, this pilot
study was informative and we propose the following rec-
ommendations to facilitate the design and recruitment of
future UK case–control investigations involving childhood
and young adult cancer:
1. Close collaboration with primary care and the
National Institute for Health Research (NIHR)
Comprehensive Clinical Research Network (CCRN),
a body which oversees all clinical NHS-based
research in England and which supports widening
research participation to improve patient benefit
across all clinical domains. This will help to optimise
recruitment for both cases and controls.
2. Engagement with the PCRN and National Cancer
Research Institute (NCRI) Primary Care Clinical
Studies Group (CSG) to identify general practices
which are familiar with research studies, the latter a
professional group helping to develop major primary
care oncology research studies in the UK.
3. Collaboration with the relevant Childhood Cancer
and Leukaemia Group (CCLG) sub-group, e.g. the
CNS sub-group, a national group of professionals
dedicated to improving the delivery of care for
young people with cancer.
4. Collection of saliva samples for the purposes of
molecular or genetic epidemiology.
Both Leeds and Manchester experienced a number of
problems relating to recruitment of controls via GP
practices. In Leeds, procedures for identifying controls
were resource intensive leading to a much lower than
anticipated recruitment rate of 31%. The delayed start
in Manchester meant adhering to new NHS structures
Table 2 Results of the Logistic Regression modelling according to selected risk factors
Cases Controls Odds ratio* 95% confidence interval
n % n %
Ever breastfed?
No 12 24.5 13 16.7 REF
Yes 32 65.3 62 79.5 0.4 0.2 1.2
Missing 5 10.2 3 3.9
Caesarean section?
No 33 67.4 63 80.8 REF
Yes 11 22.5 11 14.1 1.6 0.6 4.4
Missing 5 10.2 4 5.1
Birthweight (g)
<2500 2 4.1 3 3.9 1.5 0.2 11.9
2500-2999 4 8.2 12 15.4 1.0 0.2 4.0
3000-3499 11 22.5 30 38.5 REF
3500-3999 16 32.7 16 20.5 2.9 1.0 8.2
4000+ 11 22.5 9 11.5 3.7 1.1 12.4
Missing 5 10.2 8 10.3
Number of siblings
0 5 10.2 8 10.3 REF
1 20 40.8 37 47.4 1.1 0.3 4.3
2 9 18.4 21 26.9 1.0 0.2 4.3
3+ 15 30.6 9 11.5 3.0 0.7 13.6
Missing 0 0.0 3 3.9
Spoken on a mobile phone more than 20 times?
No 23 46.9 28 35.9 REF
Yes 26 53.1 49 62.8 0.9 0.2 3.3
Missing 0 0.0 1 1.3
Any animals kept at home?
No 11 22.5 14 17.9 REF
Yes 38 77.5 62 79.5 1.0 0.3 2.9
Missing 0 0.0 2 2.6
Regular contact with animals outside the home?
No 35 71.4 47 60.3 REF
Yes 14 28.6 31 39.7 0.7 0.3 1.5
Missing 0 0.0 0 0.0
*Odds ratios calculated using conditional logistic regression stratified by age (5-year groups) and sex, analyses were adjusted for deprivation by the use of
Townsend score quintiles based on the UK population distribution.
REF, Reference category.
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Caldicott Guardian approval for the control recruitment
protocol and acceptance of the study onto the NIHR/
PCRN portfolio, little progress was made in identifying
GP practices willing to participate in the research. Ex-
haustive efforts over a long period of time were made
by the Manchester staff to engage with general practices
both through the PCRN and directly to practices with
little success.We believe that the new NHS General Medical Services
contract for General Practice, which was implemented in
2004 and allocated certain resources to GPs based on how
well they manage patient care (the Quality and Outcomes
Framework), may have influenced the willingness of GP
practices throughout Manchester to participate. We have
since taken advice from the national NCRI Primary Care
CSG to help develop control recruitment procedures for
future research by ensuring that we work closely with the
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of control subjects such as child health records through
our existing links with primary care.
Completion of the questionnaire was a success, with a
very small proportion of missing data being reported.
The collection of biological samples would be an integral
part of future epidemiological research in this field. We
explored the possibility of exploiting the national CCLG
tumour bank samples in conjunction with case control
research projects. The Brain Tumour sub-group of the
CCLG was fully supportive and indicated willingness to
collaborate with future studies. All tumour and blood
samples collected by the CCLG adhere to specific proto-
cols which would be closely mirrored in future studies.
Although we did not collect biological material, we did
however ask participants about their willingness to
provide biological samples and there was a clear consensus
in favour of taking either blood or saliva to aid molecular
epidemiological research. Participants also stated that
saliva samples would be more readily donated than
blood, particularly from younger controls.
Although our pilot study had limited statistical power,
findings agreed with previous aetiological work in showing
an increased risk associated with birthweight greater
than 3500 g [24]. However, our reported non-significant
protective association with breastfeeding is contrary to
previous findings [27,28] and may have been due to
chance. The use of friend controls may have led to a
degree of overmatching, although the number of partici-
pants selected in this manner (n = 3) is unlikely to have
had a major effect on the parameter estimates reported in
Table 2. Control participation in Leeds was also related to
deprivation, with higher levels of participation from more
affluent areas. This potential participation bias may have
contributed to the higher observed rates of breastfeeding,
smaller sibling size and mobile phone usage in the control
sample. Nevertheless, as we reported the results for a
selected range of risk factors from a relatively small
feasibility study, odds ratios should be interpreted with
due caution and not be taken as evidence or absence of
any causal association.
Feedback from participants has provided us with key
information with which to revise the study questionnaires
and recruitment procedures to ensure that participation
rates in future case–control studies can be maximised. It
has provided a valuable insight into questionnaire design
and recruitment procedures, particularly in terms of
overcoming problems associated with the identification
of suitable healthy control subjects.
Conclusions
In summary, this pilot has provided us with all the elements
necessary to produce a full protocol for a future UK
study, including extensive documentation on all aspectsof recruiting and approaching case and control subjects
and their families. Findings from this pilot will provide
essential information for refining the methods for a future
large, multi-centre case–control study.
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